Interpharm Holdings Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IPAH has 66.74 million shares outstanding.
| Current Share Class | 66.74M |
| Shares Outstanding | 66.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 3.43.
| Current Ratio | 0.62 |
| Quick Ratio | 0.31 |
| Debt / Equity | 3.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.30 |
| Interest Coverage | -7.99 |
Financial Efficiency
Return on equity (ROE) is -117.07% and return on invested capital (ROIC) is -23.72%.
| Return on Equity (ROE) | -117.07% |
| Return on Assets (ROA) | -18.53% |
| Return on Invested Capital (ROIC) | -23.72% |
| Return on Capital Employed (ROCE) | -97.33% |
| Revenue Per Employee | 103,300 |
| Profits Per Employee | -50,290 |
| Employee Count | 670 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 5.19 |
Taxes
In the past 12 months, IPAH has paid 7.09 million in taxes.
| Income Tax | 7.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is -58.12, so IPAH's price volatility has been lower than the market average.
| Beta (5Y) | -58.12 |
| 52-Week Price Change | -99.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.07 |
| Average Volume (20 Days) | 14,652 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 57.07 |
Income Statement
In the last 12 months, IPAH had revenue of 69.21 million and -33.69 million in losses. Loss per share was -0.51.
| Revenue | 69.21M |
| Gross Profit | 12.00M |
| Operating Income | -19.78M |
| Pretax Income | -22.27M |
| Net Income | -33.69M |
| EBITDA | -16.57M |
| EBIT | -19.78M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 41,000 in cash and 38.47 million in debt, giving a net cash position of -38.43 million or -0.58 per share.
| Cash & Cash Equivalents | 41,000 |
| Total Debt | 38.47M |
| Net Cash | -38.43M |
| Net Cash Per Share | -0.58 |
| Equity (Book Value) | 11.21M |
| Book Value Per Share | -0.08 |
| Working Capital | -16.64M |
Cash Flow
In the last 12 months, operating cash flow was -21.75 million and capital expenditures -7.86 million, giving a free cash flow of -29.61 million.
| Operating Cash Flow | -21.75M |
| Capital Expenditures | -7.86M |
| Free Cash Flow | -29.61M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 17.34%, with operating and profit margins of -28.58% and -42.42%.
| Gross Margin | 17.34% |
| Operating Margin | -28.58% |
| Pretax Margin | -32.18% |
| Profit Margin | -42.42% |
| EBITDA Margin | -23.94% |
| EBIT Margin | -28.58% |
| FCF Margin | n/a |
Dividends & Yields
IPAH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.21% |
| Shareholder Yield | n/a |
| Earnings Yield | -50,289,552.24% |
| FCF Yield | -44,188,059.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 19, 1997. It was a reverse split with a ratio of 0.2.
| Last Split Date | Nov 19, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
IPAH has an Altman Z-Score of -0.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.02 |
| Piotroski F-Score | 2 |